Quinoxaline, identified by CAS number 91-19-0, is a significant heterocyclic compound that bridges the fields of organic synthesis and pharmaceutical development. Its unique molecular structure, a fusion of benzene and pyrazine rings, renders it a valuable building block for chemists seeking to create complex molecular architectures.

The compound's role as a pharmaceutical intermediate is particularly noteworthy. Quinoxaline serves as a foundational component in the synthesis of various drugs, underscoring its importance in the medicinal chemistry pipeline. The potential for structural modification of the quinoxaline scaffold opens avenues for discovering new therapeutic agents with targeted biological activities.

Key chemical data for quinoxaline, including its molecular formula (C8H6N2), molecular weight (130.14700), and physical properties such as its melting point (29-32 °C) and boiling point (220-223 °C), are critical for its effective application in synthesis. For businesses and researchers looking to purchase quinoxaline, understanding these specifications ensures they acquire a product suitable for their needs. The price of quinoxaline is influenced by its quality and the efficiency of its production, making it a sought-after chemical for advanced applications. The ongoing exploration of quinoxaline synthesis methods continues to drive its accessibility and utility.